Nav: Home

Low-protein diet during pregnancy increases prostate cancer risk in offspring

August 06, 2018

The offspring of females fed a low-protein diet during pregnancy and lactation are significantly more likely to develop prostate cancer as they age.

This is the main finding of a study performed with rats at São Paulo State University's Bioscience Institute (IBB-UNESP) in Botucatu, Brazil. The results of the study, which was supported by the São Paulo Research Foundation (FAPESP), have been published in The Journals of Gerontology: Series A.

"Our previous research showed that intrauterine exposure to a low-protein diet impairs prostate development. Our latest published study proves that this effect observed postnatally increases the incidence of prostate disease when the individuals concerned are older," said Luis Antonio Justulin Junior, a professor at IBB-UNESP and principal investigator for the study.

The model used in Justulin's laboratory consists of feeding pregnant females a diet with only 6% protein. Laboratory rats are normally fed a diet that contains between 17% and 23% protein.

"Data in the literature show 12% to be the minimum protein content needed for rats to carry a pregnancy to term without problems," Justulin said.

The pregnant rats included in the study were divided into three groups. The control group was fed the standard diet with at least 17% protein during pregnancy and a 21-day lactation period. After weaning, the offspring were also fed the standard diet. No cases of prostate cancer were found in these offspring 540 days after birth, when rats were considered old.

The second group of females were fed the 6% protein diet only during pregnancy. After giving birth, they were fed the standard diet, as were their weaned offspring. In the assessment performed 540 days after birth, 33% of their male offspring had developed prostate cancer. The third group was fed the low-protein diet throughout pregnancy and lactation, and 50% of their offspring developed prostate cancer.

"We performed a histopathological analysis on these animals' prostates, and in all three groups, we found preneoplastic alterations capable of interfering with glandular function, such as hyperplasia, epithelial atrophy and intraepithelial neoplasia; the latter has the potential to become carcinoma, according to data in the scientific literature," said the FAPESP-supported researcher. "However, cancer was found only in the animals exposed to the low-protein diet in their intrauterine life."

Hormone imbalance

The previous study, published in 2017 in General and Comparative Endocrinology, described some of the impairments caused in offspring by a maternal low-protein diet.

The analysis performed on the tenth and twentieth days after birth showed that compared with prostates in the offspring of females fed the normal diet, those in the offspring of females fed the low-protein diet were smaller and had fewer differentiated epithelial cells, which is considered a sign of retarded development. The prostate also displayed functional impairment, secreting and storing less prostate fluid.

It is worth recalling that the function of the prostate is to produce the fluid that protects and nourishes sperm in semen, making it more dilute.

"Generally speaking, these animals had low birth weight, less developed organs, and altered hormone levels," Justulin said. "However, around the twenty-first day after birth, we began to see accelerated growth to try to make up for the deficit."

In a recently published study, researchers collected blood from male pups on postnatal days 21 and 540. They found an imbalance between female and male hormone levels between the offspring of mothers fed a low-protein diet and the offspring of the control group.

While control males had 15 picograms (pg) of estrogen on PND 21, males born to rats fed the low-protein diet during pregnancy and lactation had 20 pg. On PND 540, the difference was even greater: 14 pg versus 35 pg, respectively.

Moreover, on PND 540, increased female hormone levels were associated with a decrease in the level of testosterone, the main male hormone. Control mice had 5 nanograms (ng), while those from the low-protein diet group had only 0.8 ng.

According to Justulin, no decrease in testosterone was observed in the low-protein diet group on PND 21 because this is the stage at which rat pups are growing the fastest.

"Our prior research showed that pups exposed to an intrauterine low-protein diet were born small but that as young adults they no longer displayed differences compared with controls in terms of size, prostate volume or hormone levels," said the FAPESP research project coordinator. "In our new study, the differences reappeared as they aged. It's as if aging were a second insult to the organism, considering that the first was the low-protein diet in the initial stage of development."

Researchers are now testing the hypothesis that exposure to altered hormone levels in old age favors carcinogenesis (tumor formation).

"We observed this in the prostate, but other studies show low birth weight induced by maternal undernourishment is correlated with altered insulin levels and increased incidence of metabolic syndrome and heart disease," Justulin said.

The research group at IBB-UNESP is currently investigating sex hormone synthesis pathways with the aim of understanding how a low-protein diet affects the estrogen-testosterone balance. They also want to demonstrate the mechanism through which hormone imbalance can favor the development of prostate cancer.

Preliminary results of this research point to dysregulated messenger RNAs and microRNAs in the restricted-diet animals on postnatal day 21.

"We found several messenger RNAs and microRNAs that were dysregulated in both pups at 21 days and 540-day-old animals with cancer," Justulin said. "What's interesting is that some of these molecules are also altered in human patients with prostate tumors, according to our analysis of public genome databases with the aid of bioinformatics tools."
About São Paulo Research Foundation (FAPESP)

The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. For more information:

Fundação de Amparo à Pesquisa do Estado de São Paulo

Related Prostate Cancer Articles:

ASCO and Cancer Care Ontario update guideline on radiation therapy for prostate cancer
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer.
Patient prostate tissue used to create unique model of prostate cancer biology
For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track how the tumor progresses.
Moffitt Cancer Center awarded $3.2 million grant to study bone metastasis in prostate cancer
Moffitt researchers David Basanta, Ph.D., and Conor Lynch, Ph.D., have been awarded a U01 grant to investigate prostate cancer metastasis.
New findings concerning hereditary prostate cancer
For the first time ever, researchers have differentiated the risks of developing indolent or aggressive prostate cancer in men with a family history of the disease.
Prostate cancer discovery may make it easier to kill cancer cells
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy.
New test for prostate cancer significantly improves prostate cancer screening
A study from Karolinska Institutet in Sweden shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
The dilemma of screening for prostate cancer
Primary care providers are put in a difficult position when screening their male patients for prostate cancer -- some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate in certain patients.
Risk factors for prostate cancer
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and vasectomy also add to the risk.
Prostate cancer is 5 different diseases
Cancer Research UK scientists have for the first time identified that there are five distinct types of prostate cancer and found a way to distinguish between them, according to a landmark study published today in EBioMedicine.
UH Seidman Cancer Center performs first-ever prostate cancer treatment
The radiation oncology team at UH Seidman Cancer Center in Cleveland performed the first-ever prostate cancer treatment April 3 using a newly-approved device -- SpaceOAR which enhances the efficacy of radiation treatment by protecting organs surrounding the prostate.

Related Prostate Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...